Allurion Technologies (ALUR) Competitors $2.97 +0.14 (+4.95%) As of 02:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALUR vs. FONR, MLSS, SRTS, INO, ZYXI, OM, EDAP, NSPR, BSGM, and VANIShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include FONAR (FONR), Milestone Scientific (MLSS), Sensus Healthcare (SRTS), Inovio Pharmaceuticals (INO), Zynex (ZYXI), Outset Medical (OM), Edap Tms (EDAP), InspireMD (NSPR), BioSig Technologies (BSGM), and Vivani Medical (VANI). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. FONAR Milestone Scientific Sensus Healthcare Inovio Pharmaceuticals Zynex Outset Medical Edap Tms InspireMD BioSig Technologies Vivani Medical Allurion Technologies (NYSE:ALUR) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, community ranking, profitability, valuation, institutional ownership and risk. Does the MarketBeat Community believe in ALUR or FONR? FONAR received 173 more outperform votes than Allurion Technologies when rated by MarketBeat users. Likewise, 74.79% of users gave FONAR an outperform vote while only 66.67% of users gave Allurion Technologies an outperform vote. CompanyUnderperformOutperformAllurion TechnologiesOutperform Votes866.67% Underperform Votes433.33% FONAROutperform Votes18174.79% Underperform Votes6125.21% Do institutionals and insiders hold more shares of ALUR or FONR? 21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 22.4% of Allurion Technologies shares are held by insiders. Comparatively, 1.6% of FONAR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts recommend ALUR or FONR? Allurion Technologies currently has a consensus price target of $22.83, suggesting a potential upside of 668.80%. Given Allurion Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Allurion Technologies is more favorable than FONAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allurion Technologies 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00FONAR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ALUR or FONR more profitable? FONAR has a net margin of 7.68% compared to Allurion Technologies' net margin of -71.24%. FONAR's return on equity of 4.94% beat Allurion Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Allurion Technologies-71.24% N/A -56.75% FONAR 7.68%4.94%3.70% Does the media favor ALUR or FONR? In the previous week, Allurion Technologies had 4 more articles in the media than FONAR. MarketBeat recorded 6 mentions for Allurion Technologies and 2 mentions for FONAR. Allurion Technologies' average media sentiment score of 0.53 beat FONAR's score of 0.42 indicating that Allurion Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allurion Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive FONAR 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, ALUR or FONR? Allurion Technologies has a beta of -0.58, meaning that its stock price is 158% less volatile than the S&P 500. Comparatively, FONAR has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500. Which has stronger valuation & earnings, ALUR or FONR? FONAR has higher revenue and earnings than Allurion Technologies. Allurion Technologies is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllurion Technologies$32.11M0.69-$80.61M-$12.50-0.24FONAR$103.02M0.84$10.57M$1.2511.16 SummaryFONAR beats Allurion Technologies on 12 of the 19 factors compared between the two stocks. Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$22.15M$4.44B$5.35B$19.37BDividend YieldN/A43.63%5.21%3.83%P/E Ratio-0.2529.3426.9134.60Price / Sales0.6966.00390.0635.27Price / CashN/A51.0838.2517.51Price / Book-0.086.226.794.70Net Income-$80.61M$67.60M$3.23B$1.02B7 Day Performance3.48%-0.44%1.99%-1.62%1 Month Performance30.55%18.25%11.45%7.65%1 Year Performance-92.71%21.27%17.35%4.34% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies3.4593 of 5 stars$2.97+4.9%$22.83+668.8%-93.3%$22.15M$32.11M-0.25501Analyst UpgradeAnalyst RevisionGap UpFONRFONAR1.7965 of 5 stars$13.51+4.7%N/A-4.9%$83.91M$101.57M11.75480News CoveragePositive NewsEarnings ReportAnalyst UpgradeHigh Trading VolumeMLSSMilestone Scientific1.1433 of 5 stars$1.02+14.0%$1.25+22.5%+26.5%$79.95M$8.63M-14.5730Gap DownSRTSSensus Healthcare2.7077 of 5 stars$4.73+6.1%$11.67+146.7%-20.7%$78.02M$41.81M11.8340News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionINOInovio Pharmaceuticals3.6533 of 5 stars$2.07+1.0%$9.75+371.0%-82.0%$75.92M$217,756.00-0.65320ZYXIZynex3.0269 of 5 stars$2.36-4.8%$6.00+154.2%-78.5%$74.99M$172.40M15.73770OMOutset Medical1.2424 of 5 stars$19.58+0.4%$24.67+26.0%-66.3%$70.39M$115.27M-7.90520Analyst ForecastHigh Trading VolumeEDAPEdap Tms1.831 of 5 stars$1.86+5.7%$8.50+357.0%-71.0%$69.55M$64.12M-2.86230Earnings ReportAnalyst RevisionNSPRInspireMD2.2409 of 5 stars$2.26-4.2%$4.50+99.1%-4.7%$69.24M$7.03M-3.0150BSGMBioSig Technologies0.3735 of 5 stars$2.85+9.2%$2.50-12.3%+79.3%$69.12M$40,000.000.0050Earnings ReportGap UpVANIVivani Medical3.1257 of 5 stars$1.07+3.9%$4.00+273.8%-36.7%$63.39MN/A-2.3820News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies FONAR Competitors Milestone Scientific Competitors Sensus Healthcare Competitors Inovio Pharmaceuticals Competitors Zynex Competitors Outset Medical Competitors Edap Tms Competitors InspireMD Competitors BioSig Technologies Competitors Vivani Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALUR) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALUR Stock Free ALUR Stock Alerts